2’,3’,5’-Tri-O-benzyl-4’-thio-arabinouridine

Modify Date: 2024-01-20 18:29:43

2’,3’,5’-Tri-O-benzyl-4’-thio-arabinouridine Structure
2’,3’,5’-Tri-O-benzyl-4’-thio-arabinouridine structure
 Common Name 2’,3’,5’-Tri-O-benzyl-4’-thio-arabinouridine
CAS Number 267665-69-0 Molecular Weight N/A
Density N/A Boiling Point N/A
Molecular Formula N/A Melting Point N/A
MSDS N/A Flash Point N/A

 Use of 2’,3’,5’-Tri-O-benzyl-4’-thio-arabinouridine


2’,3’,5’-Tri-O-benzyl-4’-thio-arabinouridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

 Names

Name 2',3',5'-Tri-O-benzyl-4'-thio-arabinouridine

  Biological Activity

Description 2’,3’,5’-Tri-O-benzyl-4’-thio-arabinouridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Related Catalog
References

[1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.  

 Chemical & Physical Properties

No Any Chemical & Physical Properties
Top Suppliers:I want be here
Related Compounds: More...
Xanthylium, 9-[2-(ethoxycarbonyl)phenyl]-3,6-bis(ethylamino)-2,7-dimethyl-, (T-4)-hydroxy[2-(hydroxy-kappaO)-5-nitro-3-[2-[2-(oxo-kappaO)-1-[(phenylamino)carbonyl]propyl]diazenyl-kappaN1]benzenesulfonato(3-)]chromate(1-) (1:1)
94276-35-4
Cuprate(6-), [mu-[[2,2'-[(1-oxido-1,2-diazenediyl)bis[(2-sulfo-4,1-phenylene)-2,1-ethenediyl(3-sulfo-4,1-phenylene)-2,1-diazenediyl[1-(hydroxy-kappaO)-3-sulfo-7,2-naphthalenediyl]-2,1-diazenediyl-kappaN1]]bis[benzoato-kappaO]](10-)]]di-, hydrogen (1:6)
66225-60-3
Xanthylium, 9-(2-(ethoxycarbonyl)phenyl)-3,6-bis(ethylamino)-2,7-dimethyl-, bis(2-(hydroxy-kappaO)-5-nitro-3-((2-(oxo-kappaO)-1-((phenylamino)carbonyl)propyl)azo-kappaN1)benzenesulfonato(3-))chromate(3-) (3:1)
72986-48-2
Cuprate(5-), [4-amino-3-[2-(2,5-disulfophenyl)diazenyl]-5-(hydroxy-kappaO)-6-[2-[2-(hydroxy-kappaO)-5-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl-kappaN1]-2,7-naphthalenedisulfonato(7-)]-, hydrogen (1:5)
72208-06-1
Cuprate(5-), [mu-[2-[2-[1-[4-[2-[4-[2-[4-[2-[6-(acetylamino)-1-(hydroxy-kappaO)-3-sulfo-2-naphthalenyl]diazenyl-kappaN1]-3-(hydroxy-kappaO)-7-sulfo-1-naphthalenyl]diazenyl]-2-sulfophenyl]ethenyl]-3-sulfophenyl]-4,5-dihydro-3-methyl-5-(oxo-kappaO)-1H-pyrazol-4-yl]diazenyl-kappaN1]-5-sulfobenzoato(9-)-kappaO]]di-, sodium (1:5)
75284-37-6
Dicopper;pentasodium;2-[[1-[4-[2-[4-[[4-anilino-6-[4-[2-[4-[4-[(2-carboxylatophenyl)diazenyl]-3-methyl-5-oxopyrazol-4-id-1-yl]-2-sulfonatophenyl]ethenyl]-3-sulfonatoanilino]-1,3,5-triazin-2-yl]amino]-2-sulfonatophenyl]ethenyl]-3-sulfonatophenyl]-3-methyl-5-oxopyrazol-4-id-4-yl]diazenyl]-5-sulfonatobenzoate
84196-28-1
Cuprate(4-), ammineaqua[mu-[7-(benzoylamino)-3-[2-[3,3'-di(hydroxy-kappaO)-4'-[2-[1-(hydroxy-kappaO)-4,8-disulfo-2-naphthalenyl]diazenyl-kappaN1][1,1'-biphenyl]-4-yl]diazenyl-kappaN1]-4-(hydroxy-kappaO)-1,5-naphthalenedisulfonato(8-)]]di-, sodium (1:4)
86242-91-3
Cuprate(4-), [7-[(5-chloro-2-fluoro-6-methyl-4-pyrimidinyl)amino]-4-(hydroxy-kappaO)-3-[2-[2-(hydroxy-kappaO)-8-hydroxy-4,6-disulfo-1-naphthalenyl]diazenyl-kappaN1]-1,5-naphthalenedisulfonato(6-)]-, sodium (1:4)
75199-09-6
Tetrapotassium (7-((5-chloro-2,6-difluoro-4-pyrimidinyl)amino)-4-hydroxy-3-((2-hydroxy-4,7-disulpho-1-naphthyl)azo)naphthalene-1,5-disulphonato(6-))cuprate(4-)
71735-60-9
Cuprate(1-), [4-[4,5-dihydro-4-[2-[2-(hydroxy-kappaO)-5-nitrophenyl]diazenyl-kappaN1]-3-methyl-5-(oxo-kappaO)-1H-pyrazol-1-yl]benzenesulfonato(3-)]-, hydrogen (1:1)
73297-22-0
Chemsrc provides CAS#:267665-69-0 MSDS, density, melting point, boiling point, structure, etc. Its name is 2’,3’,5’-Tri-O-benzyl-4’-thio-arabinouridine>> amp version: 2’,3’,5’-Tri-O-benzyl-4’-thio-arabinouridine

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved